New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Advances Amgen's mission to serve patients with rare disease medicines
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
